{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T01:10:13Z","timestamp":1738977013583,"version":"3.37.0"},"reference-count":27,"publisher":"American Association of Psychiatric Pharmacists (AAPP)","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p>Weight loss surgery has become more common in the United States because of the increasing rates of obesity. The physiological changes caused by weight loss surgery have the potential for clinically significant changes in the pharmacokinetic parameters of mood stabilizers, including valproic acid (VPA). A patient with a history of Roux-en-Y gastric bypass and bipolar disorder was hospitalized because of mania. The dosing regimen of the VPA was changed multiple times due to unexpectedly low and inconsistent trough levels. Despite a significant increase in the total daily dose, the final trough level obtained was not significantly different than the initial level. The VPA was changed from the delayed-release to the immediate-release formulation to achieve better absorption. However, no trough level was obtained after this change. Weight loss surgeries, such as Roux-en-Y gastric bypass, may continue to impact the pharmacokinetic parameters of VPA for several years after the procedure. This patient was titrated to a dose of 39 mg\/kg\/day (typical range 20-30 mg\/kg\/day) with minimal change in level. Pharmacokinetic changes are a concern in the use of mood stabilizers, including VPA, after weight loss surgery. Close monitoring is essential for safe and effective treatment. If strict drug level monitoring is not an option, it may be preferable to consider an alternative mood-stabilizing treatment. Switching to the immediate-release formulation of VPA may also be an option; however, further investigation is required to determine if this makes a clinical difference in the management of bipolar disorder.<\/jats:p>","DOI":"10.9740\/mhc.2025.02.025","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:31:01Z","timestamp":1738974661000},"page":"25-29","source":"Crossref","is-referenced-by-count":0,"title":["Impact of weight loss surgery on valproic acid levels: A case report"],"prefix":"10.9740","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2278-1018","authenticated-orcid":true,"given":"Kristin","family":"Waters","sequence":"first","affiliation":[{"name":"(Corresponding author) Assistant Clinical Professor, University of Connecticut School of Pharmacy, Storrs, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8805-7912","authenticated-orcid":true,"given":"Grace","family":"Cose","sequence":"additional","affiliation":[{"name":"PharmD Candidate, Pharmacy Student, University of Connecticut School of Pharmacy, Storrs, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6375-6621","authenticated-orcid":true,"given":"Chloe","family":"Hurme","sequence":"additional","affiliation":[{"name":"PharmD Candidate, Pharmacy Student, University of Connecticut School of Pharmacy, Storrs, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5198-5992","authenticated-orcid":true,"given":"Ashley","family":"Tewksbury","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Specialist, Yale New Haven Hospital, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4719","reference":[{"issue":"4","key":"i2168-9709-15-1-25-b01","series-title":"Obesity Medicine Association, and American Society of Anesthesiologists. Obesity (Silver Spring","first-page":"O1","article-title":"Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures - 2019 Update: Cosponsored by American Association of Clinical Endocrinologists\/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery","volume":"28","author":"Mechanick","year":"2020","unstructured":"Mechanick JI,\nApovian C,\nBrethauer S,\nTimothy Garvey W,\nJoffe AM,\nKim J, et al. Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures - 2019 Update: Cosponsored by American Association of Clinical Endocrinologists\/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Obesity (Silver Spring). 2020;28(4):O1-58. DOI: 10.1002\/oby.22719"},{"issue":"4","key":"i2168-9709-15-1-25-b02","series-title":"Surg Obes Relat Dis","first-page":"457","article-title":"American Society for Metabolic Bariatric Surgery 2018 estimate of metabolic and bariatric procedures performed in the United States","volume":"16","author":"English","year":"2020","unstructured":"English WJ,\nDeMaria EJ,\nHutter MM,\nKothari SN,\nMattar SG,\nBrethauer SA, et al. American Society for Metabolic Bariatric Surgery 2018 estimate of metabolic and bariatric procedures performed in the United States. Surg Obes Relat Dis. 2020;16(4):457-63. DOI: 10.1016\/j.soard.2019.12.022"},{"issue":"2","key":"i2168-9709-15-1-25-b03","series-title":"JAMA","first-page":"150","article-title":"Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis","volume":"315","author":"Dawes","year":"2016","unstructured":"Dawes AJ,\nMaggard-Gibbons M,\nMaher AR,\nBooth MJ,\nMiake-Lye I,\nBeroes JM, et al. Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis. JAMA. 2016;315(2):150-63. DOI:10.1001\/jama.2015.18118"},{"issue":"9","key":"i2168-9709-15-1-25-b04","series-title":"Obes Surg","first-page":"1148","article-title":"Psychiatric diagnoses and psychiatric treatment among bariatric surgery candidates","volume":"14","author":"Sarwer","year":"2004","unstructured":"Sarwer DB,\nCohn NI,\nGibbons LM,\nMagee L,\nCrerand CE,\nRaper SE, et al. Psychiatric diagnoses and psychiatric treatment among bariatric surgery candidates. Obes Surg. 2004;14(9):1148-56. DOI: 10.1381\/0960892042386922"},{"issue":"2","key":"i2168-9709-15-1-25-b05","series-title":"Obes Surg","first-page":"735","article-title":"Lithium toxicity with severe bradycardia post sleeve gastrectomy: a case report and review of the literature","volume":"29","author":"Dahan","year":"2019","unstructured":"Dahan A,\nPorat D,\nAzran C,\nMualem Y,\nSakran N,\nAbu-Abeid S. Lithium toxicity with severe bradycardia post sleeve gastrectomy: a case report and review of the literature. Obes Surg. 2019;29(2):735-8. DOI: 10.1007\/s11695-018-3597-x"},{"issue":"11","key":"i2168-9709-15-1-25-b06","series-title":"Obes Rev","first-page":"1050","article-title":"Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations","volume":"17","author":"Azran","year":"2016","unstructured":"Azran C,\nWolk O,\nZur M,\nFine-Shamir N,\nShaked G,\nCzeiger D, et al. Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations. Obes Rev. 2016;17(11):1050-66. DOI: 10.1111\/obr.12434"},{"issue":"6","key":"i2168-9709-15-1-25-b07","series-title":"Can Fam Physician","first-page":"409","article-title":"Medication management and pharmacokinetic changes after bariatric surgery","volume":"66","author":"Lorico","year":"2020","unstructured":"Lorico S,\nColton B. Medication management and pharmacokinetic changes after bariatric surgery. Can Fam Physician. 2020;66(6):409-16."},{"issue":"11","key":"i2168-9709-15-1-25-b08","series-title":"Obes Surg","first-page":"2933","article-title":"National trends in bariatric surgery 2012-2015: demographics, procedure selection, readmissions, and cost","volume":"27","author":"Kizy","year":"2017","unstructured":"Kizy S,\nJahansouz C,\nDowney MC,\nHevelone N,\nIkramuddin S,\nLeslie D. National trends in bariatric surgery 2012-2015: demographics, procedure selection, readmissions, and cost. Obes Surg. 2017;27(11):2933-9. DOI: 10.1007\/s11695-017-2719-1"},{"issue":"5","key":"i2168-9709-15-1-25-b09","series-title":"N Engl J Med","first-page":"445","article-title":"Perioperative safety in the longitudinal assessment of bariatric surgery","volume":"361","author":"Flum","year":"2009","unstructured":"Flum DR,\nBelle SH,\nKing WC,\nWahed AS,\nBerk P,\nChapman W, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009; 361(5):445-54. DOI: 10.1056\/NEJMoa0901836"},{"issue":"3","key":"i2168-9709-15-1-25-b10","series-title":"Ment Health Clin","first-page":"214","article-title":"Lithium toxicity following Roux-en-Y gastric bypass: mini review and illustrative case","volume":"12","author":"Ayub","year":"2022","unstructured":"Ayub S,\nSaboor S,\nUsmani S,\nJaved S,\nTonpouwo GK,\nAhmed S. Lithium toxicity following Roux-en-Y gastric bypass: mini review and illustrative case. Ment Health Clin. 2022;12(3):214-8. DOI: 10.9740\/mhc.2022.06.214"},{"issue":"1","key":"i2168-9709-15-1-25-b11","series-title":"World Psychiatry","first-page":"52","article-title":"Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care","volume":"10","author":"Hert","year":"2011","unstructured":"Hert MDE,\nCorrell CU,\nBobes J,\nCetkovich-Bakmas M,\nCohen D,\nAsai I, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52-77. DOI: 10.1002\/j.2051-5545.2011.tb00014.x"},{"issue":"5","key":"i2168-9709-15-1-25-b12","series-title":"J Clin Psychiatry","first-page":"634","article-title":"Are mood disorders and obesity related? A review for the mental health professional","volume":"65","author":"McElroy","year":"2004","unstructured":"McElroy SL,\nKotwal R,\nMalhotra S,\nNelson EB,\nKeck PE,\nNemeroff CB. Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry. 2004;65(5):634-730. DOI: 10.4088\/jcp.v65n0507"},{"issue":"9","key":"i2168-9709-15-1-25-b13","series-title":"Psychiatr Serv","first-page":"750","article-title":"Diagnosed mental health conditions and risk of suicide mortality","volume":"70","author":"Yeh","year":"2019","unstructured":"Yeh HH,\nWestphal J,\nHu Y,\nPeterson EL,\nWilliams LK,\nPrabhakar D, et al. Diagnosed mental health conditions and risk of suicide mortality. Psychiatr Serv. 2019;70(9):750-7. DOI: 10.1176\/appi.ps.201800346"},{"issue":"6","key":"i2168-9709-15-1-25-b14","series-title":"Surg Obes Relat Dis","first-page":"798","article-title":"Benefits and risks of bariatric surgery in patients with bipolar disorders","volume":"16","author":"Chalopin","year":"2020","unstructured":"Chalopin S,\nBetry C,\nCoumes S,\nWion N,\nReche F,\nArvieux C, et al. Benefits and risks of bariatric surgery in patients with bipolar disorders. Surg Obes Relat Dis. 2020;16(6):798-805. DOI: 10.1016\/j.soard.2020.02.010"},{"issue":"6","key":"i2168-9709-15-1-25-b15","series-title":"J Psychopharmacol","first-page":"495","article-title":"Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology","volume":"30","author":"Goodwin","year":"2016","unstructured":"Goodwin GM,\nHaddad PM,\nFerrier IN,\nAronson JK,\nBarnes T,\nCipriani A, et al. Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2016;30(6):495-553. DOI: 10.1177\/0269881116636545"},{"key":"i2168-9709-15-1-25-b16","series-title":"Depakote (divalproex sodium delayed-release tablets)","year":"2013","unstructured":"Depakote (divalproex sodium delayed-release tablets). Package insert. AbbVie Inc.; 2013."},{"key":"i2168-9709-15-1-25-b17","series-title":"Depakote ER (divalproex sodium extended-release tablets)","year":"2013","unstructured":"Depakote ER (divalproex sodium extended-release tablets). Package insert. AbbVie Inc.; 2013."},{"issue":"12","key":"i2168-9709-15-1-25-b18","series-title":"J Clin Psychiatry","first-page":"815","article-title":"Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients","volume":"60","author":"Hirschfeld","year":"1999","unstructured":"Hirschfeld RM,\nAllen MH,\nMcEvoy JP,\nKeck PE Jr,\nRussell JM. Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. J Clin Psychiatry. 1999;60(12):815-8. DOI: 10.4088\/jcp.v60n1202"},{"issue":"1","key":"i2168-9709-15-1-25-b19","series-title":"Cancer Chemother Pharmacol","first-page":"25","article-title":"Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data","volume":"94","author":"Lau","year":"2024","unstructured":"Lau C,\nAli MIM,\nLin L,\nvan Balen DEM,\nJacobs BAW,\nNuijen B, et al. Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data. Cancer Chemother Pharmacol. 2024;94(1):25-34. DOI: 10.1007\/s00280-024-04640-0"},{"key":"i2168-9709-15-1-25-b20","series-title":"J Invest Med High Impact Case Rep","article-title":"Ineffective absorption? Failure of direct-acting therapy for chronic hepatitis C in cirrhotic patients with Roux-en-Y gastric bypass","volume":"7","author":"Tow","year":"2019","unstructured":"Tow CY,\nReinus JF. Ineffective absorption? Failure of direct-acting therapy for chronic hepatitis C in cirrhotic patients with Roux-en-Y gastric bypass. J Invest Med High Impact Case Rep. 2019;7. DOI: 10.1177\/2324709619858127"},{"key":"i2168-9709-15-1-25-b21","series-title":"Epilepsy Behav Rep","first-page":"100439","article-title":"Antiseizure medication use in gastric bypass patients and other post-surgical malabsorptive states","volume":"16","author":"Brown","year":"2021","unstructured":"Brown CS,\nRabinstein AA,\nNystrom EM,\nBritton JW,\nSingh TD. Antiseizure medication use in gastric bypass patients and other post-surgical malabsorptive states. Epilepsy Behav Rep. 2021;16:100439. DOI: 10.1016\/j.ebr.2021.100439"},{"issue":"5","key":"i2168-9709-15-1-25-b22","series-title":"Psychosomatics","first-page":"454","article-title":"Intravenous valproate treatment of severe manic symptoms after gastric bypass surgery: a case report","volume":"41","author":"Kaltsounis","year":"2000","unstructured":"Kaltsounis J,\nDe Leon OA. Intravenous valproate treatment of severe manic symptoms after gastric bypass surgery: a case report. Psychosomatics. 2000;41(5):454-6."},{"issue":"3","key":"i2168-9709-15-1-25-b23","series-title":"J Neuropsychiatry Clin Neurosci","first-page":"427","article-title":"Intravenous valproate use in bipolar II disorder after gastric bypass surgery","volume":"17","author":"Semion","year":"2005","unstructured":"Semion K,\nDorsey J,\nBourgeois J. Intravenous valproate use in bipolar II disorder after gastric bypass surgery. J Neuropsychiatry Clin Neurosci. 2005;17(3):427-9. DOI: 10.1176\/jnp.17.3.427-a"},{"issue":"3","key":"i2168-9709-15-1-25-b24","series-title":"Epilepsy Res","first-page":"275","article-title":"Distinct absorption characteristics of oral formulations of valproic acid\/divalproex available in the United States","volume":"73","author":"Dutta","year":"2007","unstructured":"Dutta S,\nReed RC. Distinct absorption characteristics of oral formulations of valproic acid\/divalproex available in the United States. Epilepsy Res. 2007;73(3):275-83. DOI: 10.1016\/j.eplepsyres.2006.11.005"},{"issue":"4","key":"i2168-9709-15-1-25-b25","series-title":"J Formos Med Assoc","first-page":"1114","article-title":"Factors to influence the accuracy of albumin adjusted free valproic acid concentration","volume":"120","author":"Tseng","year":"2021","unstructured":"Tseng YJ,\nHuang SY,\nKuo CH,\nWang CY,\nWang KC,\nWu CC. Factors to influence the accuracy of albumin adjusted free valproic acid concentration. J Formos Med Assoc. 2021;120(4):1114-20. DOI: 10.1016\/j.jfma.2020.09.004"},{"issue":"6","key":"i2168-9709-15-1-25-b26","series-title":"San Paulo Med J","first-page":"598","article-title":"Changes in serum albumin and liver enzymes following three different types of bariatric surgery: six-month follow-up. A retrospective cohort study","volume":"139","author":"Zadeh","year":"2021","unstructured":"Zadeh MH,\nZamaninour N,\nAnsar H,\nKabir A,\nPazouki A,\nFarsani GM. Changes in serum albumin and liver enzymes following three different types of bariatric surgery: six-month follow-up. A retrospective cohort study. San Paulo Med J. 2021;139(6):598-606. DOI: 10.1590\/1516-3180.2021.00065.R1.1504221"},{"issue":"12","key":"i2168-9709-15-1-25-b27","series-title":"Obes Surg","first-page":"1827","article-title":"Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience","volume":"22","author":"Lee","year":"2012","unstructured":"Lee WJ,\nSer KH,\nLee YC,\nTsou JJ,\nChen SC,\nChen JC. Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22(12):1827-34. DOI: 10.1007\/s11695-012-0726-9"}],"container-title":["Mental Health Clinician"],"original-title":[],"link":[{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/15\/1\/article-p25.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/mhc.kglmeridian.com\/downloadpdf\/journals\/mhcl\/15\/1\/article-p25.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/mhc.kglmeridian.com\/downloadpdf\/journals\/mhcl\/15\/1\/article-p25.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:31:19Z","timestamp":1738974679000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/15\/1\/article-p25.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":27,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.9740\/mhc.2025.02.025","relation":{},"ISSN":["2168-9709"],"issn-type":[{"value":"2168-9709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}